Publication Cover
Human Fertility
an international, multidisciplinary journal dedicated to furthering research and promoting good practice
Volume 14, 2011 - Issue 1
342
Views
5
CrossRef citations to date
0
Altmetric
Luteal Phase

Luteal phase defect: part of the infertility zeitgeist or relic from the past?

, &
Pages 60-63 | Published online: 08 Dec 2010

References

  • Balasch, J., & Vanrell J. (1987). Corpus luteum insufficiency and fertility: a matter of controversy. Human Reproduction, 2, 557–567.
  • Balasch, J., Fábregues, F., Creus, M., & Vanrell, J.A. (1992). The usefulness of endometrial biopsy for luteal phase evaluation in infertility. Human Reproduction, 7, 973–977.
  • Balasch, J., Jove, I., Marquez, M., & Vanrell, J. (1990). Early follicular phase follicle-stimulating hormone treatment of endometrial luteal phase deficiency. Fertility and Sterility, 54, 1004–1007.
  • Balasch, J., Vanrell, J.A., Marquez, M., Burzaco, I., & Gonzalez-Merlo, J. (1982). Dehydrogesterone versus vaginal progesterone in the treatment of the endometrial luteal phase deficiency. Fertility and Sterility, 37, 751–754.
  • Borenstein, R., Katz, Z., Lancet, M., Caspi, B., & Ben-David, M. (1980). Bromocriptine treatment of hyperprolactinemic infertility with ovulatory disturbances. International Journal of Gynaecology and Obstetrics, 18, 195–199.
  • Bukulmez, O., & Arici, A. (2004). Luteal phase defect: myth or reality. Obstetrics and Gynecology Clinics of North America, 31, 727–744.
  • Burney, R.O., Schust, D.J., & Yao, M.W.M. (2007). Infertility. In: J.S. Berek (Ed), Berek & Novak's Gynecology (1226–1227). Philadelphia, PA: Lippincott Williams & Wilkins;
  • Check, J.H. & Adelson, H.G. (1987). The efficacy of progesterone in achieving successful pregnancy: II, in women with pure luteal phase defects. International Journal of Fertility, 32, 139–141.
  • Check, J.H., Nowroozi, K., Wu, C.H., Adelson, H.G., & Lauer, C. (1988). Ovulation-inducing drugs versus progesterone therapy for infertility in patients with luteal phase defects. International Journal of Fertility, 33, 252–256.
  • Daly, D.C. (1991). Current treatment strategies for luteal phase deficiency. In: M.R. Soules (Ed), Clinical obstetrics and gynecology (222–231). Philadelphia: JB Lippincott;
  • Davis, O.K., Berkeley, A.S., Naus, G.J., Cholst, I.N., & Freedman, K.S. (1989). The incidence of luteal phase defect in normal fertile women, determined by serial endometrial biopsies. Fertility and Sterility, 51, 582–586.
  • Del Pozo, E., Wyss, H., Tolis, G., Alcaniz, J., Campana, A., & Naftolin, F. (1979). Prolactin levels and bromocriptine treatment of short luteal phase. Obstetrics and Gynecology, 53, 282–285.
  • Downs, K., & Gibson, M. (1983). Clomiphene citrate therapy for luteal phase defect. Fertility and Sterility, 39, 34–38.
  • Fatemi, H.M., Popovic-Todorovic, B., Papanikolaou, E., Donoso, P., Devroey, P. (2007). An update of luteal phase support in stimulated IVF cycles. Human Reproduction Update, 13, 581–590.
  • Garcia, J., Jones, G.S., & Wentz, A.C. (1977). The use of clomiphene citrate. Fertility and Sterility, 28, 707–717.
  • Hammond, M., & Talbert, L. (1982). Clomiphene citrate therapy of infertile women with low luteal phase progesterone levels. Obstetrics and Gynecology, 59, 275–279.
  • Huang, K., Muechler, E., & Bonfiglio, T. (1984). Follicular phase treatment of luteal phase defect with follicle-stimulating hormone in infertile women. Obstetrics and Gynecology, 64, 32–36.
  • Jones, G.E.S. (1949). Some newer aspects of management of infertility. Journal of the American Medical Association, 141, 1123–1129.
  • Karamardian, L.M., & Grimes, D.A. (1992). Luteal phase deficiency: effect of treatment on pregnancy rates. American Journal of Obstetrics and Gynecology, 167, 1391–1398.
  • Lehtovirta, P., Arjomaa, P., Ranta, T., Laatikainen, T., Hirvonen, E., & Seppala, M. (1979). Prolactin levels and bromocriptine treatment of short luteal phase. International Journal of Fertility, 24, 57–60.
  • McNeely, M.J., & Soules, M.R. (1988). The diagnosis of luteal phase deficiency: a critical review. Fertility and Sterility, 50, 1–15.
  • Minassian, S., Wu, C., Groll, M., Gocial, B., & Goldfarb, A. (1988). Urinary follicular stimulating hormone treatment for luteal phase defect. Journal of Reproductive Medicine, 33, 11–16.
  • Nardo, L.G., & Sallam, H.N. (2006). Progesterone supplementation to prevent recurrent miscarriage and to reduce implantation failure in assisted reproduction cycles. Reproductive BioMedicine Online, 13, 47–57.
  • Noyes, R.W., Hertig, A.T., & Rock, J. (1950). Dating the endometrial biopsy. Fertility and Sterility, 1, 3–25.
  • Platteau, P., Gabbe, M., Talbot, M., & Healy, D. (2000). Two consecutive pregnancies during inadvertent gonadotropin-releasing hormone agonist desensitization. Fertility and Sterility, 73, 1244–1246.
  • Pritts, E.A., & Atwood, A.K. (2002). Luteal phase support in infertility treatment: a meta-analysis of the randomized trials. Human Reproduction, 17, 2287–2299.
  • Quagliarello, J., & Weiss, G. (1979). Clomiphene citrate in the management of infertility associated with shortened luteal phases. Fertility and Sterility, 31, 373–377.
  • Rosenberg, S.M., Luciano, A.A., & Riddick, D.H. (1980). The luteal phase defect: the relative frequency of, and encouraging response to, treatment with vaginal progesterone. Fertility and Sterility, 34, 17–20.
  • Saunders, D., Hunter, C., Haase, H., & Wilson, G. (1979). Treatment of luteal phase inadequacy with bromocriptine. Obstetrics and Gynecology, 53, 287–289.
  • Soules, M.R. (1993). Luteal dysfunction. In: E.Y. Adashi & P.C.K. Leung, (Eds), The ovary (607–627). New York: Raven Press, Ltd;
  • Soules, M.R., Wiebe, R.H., Aksel, S., & Hammond, C.B. (1977). The diagnosis and therapy of luteal phase deficiency. Fertility and Sterility, 28, 1033–1037.
  • Wentz, A.C., Kossoy, L.R., & Parker, R.A. (1990). The impact of luteal phase inadequacy in an infertile population. American Journal of Obstetrics and Gynecology, 162, 937–943.
  • Wuttke, W., Pitzel, L., Seidlova-Wuttke, D., & Hinney, B. (2001). LH pulses and the corpus luteum: the luteal phase deficiency (LPD). Vitamins and Hormones, 63, 131–158.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.